|
Adrian F. Daly M.D., M.Sc. is a member of the Medical Advisory Board of Prolong Pharmaceuticals. He has 15 years' experience in biomedical research in the pharmaceutical arena. Dr. Daly is a founder of Clinical Concepts, a European scientific consulting group that specializes in the analysis of key clinical/scientific data for the purposes of strategic planning and decision-making by the biotechnology and pharmaceutical sectors. Dr. Daly has worked with clients including Schering-Plough, Pfizer and a variety of specialty pharmaceutical and biotechnology companies. His areas of expertise include the direction of scientific analyses and competitive market profiles, the identification and verification of promising new therapeutic targets and novel measures of therapeutic efficacy. Dr. Daly is an academic member of the Endocrinology Service of the University Hospital at the University of Liège, Belgium. Dr. Daly received his medical degree from the Royal College of Surgeons in Ireland and before this graduated with a Bachelor of Science degree in Physiology from University College Dublin, Ireland. After training in General Internal Medicine, he undertook a Master of Science degree in Molecular Medicine from Trinity College, Dublin. | 